Deciphering Streptococcal Biofilms

Total Page:16

File Type:pdf, Size:1020Kb

Deciphering Streptococcal Biofilms microorganisms Review Deciphering Streptococcal Biofilms 1, 1, 2, 1 3 Puja Yadav * , Shalini Verma y, Richard Bauer y, Monika Kumari , Meenakshi Dua , Atul Kumar Johri 4, Vikas Yadav 4 and Barbara Spellerberg 2,* 1 Department of Microbiology, Central University of Haryana, Mahendergarh, Haryana 123031, India; [email protected] (S.V.); [email protected] (M.K.) 2 Institute of Medical Microbiology and Hygiene, University Hospital Ulm, 89073 Ulm, Germany; [email protected] 3 School of Environmental Sciences, Jawaharlal Nehru University, New Delhi 110067, India; [email protected] 4 School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India; [email protected] (A.K.J.); [email protected] (V.Y.) * Correspondence: [email protected] (P.Y.); [email protected] (B.S.) These authors contributed equally to this work. y Received: 19 October 2020; Accepted: 17 November 2020; Published: 21 November 2020 Abstract: Streptococci are a diverse group of bacteria, which are mostly commensals but also cause a considerable proportion of life-threatening infections. They colonize many different host niches such as the oral cavity, the respiratory, gastrointestinal, and urogenital tract. While these host compartments impose different environmental conditions, many streptococci form biofilms on mucosal membranes facilitating their prolonged survival. In response to environmental conditions or stimuli, bacteria experience profound physiologic and metabolic changes during biofilm formation. While investigating bacterial cells under planktonic and biofilm conditions, various genes have been identified that are important for the initial step of biofilm formation. Expression patterns of these genes during the transition from planktonic to biofilm growth suggest a highly regulated and complex process. Biofilms as a bacterial survival strategy allow evasion of host immunity and protection against antibiotic therapy. However, the exact mechanisms by which biofilm-associated bacteria cause disease are poorly understood. Therefore, advanced molecular techniques are employed to identify gene(s) or protein(s) as targets for the development of antibiofilm therapeutic approaches. We review our current understanding of biofilm formation in different streptococci and how biofilm production may alter virulence-associated characteristics of these species. In addition, we have summarized the role of surface proteins especially pili proteins in biofilm formation. This review will provide an overview of strategies which may be exploited for developing novel approaches against biofilm-related streptococcal infections. Keywords: streptococci; opportunistic pathogen; planktonic; biofilm; antibiotic therapy; quorum sensing (QS) 1. Introduction Biofilms are surface-associated microbial communities enclosed within a self-produced matrix consisting of a single or multiple bacterial species [1]. Following the evolution of prokaryotes several billion years ago, the evolution of biofilms is considered a defense mechanism against harsh environmental conditions by providing homeostasis and protection to the involved bacterial cells [2]. Biofilms were first observed on tooth surfaces by Antoni van Leeuwenhoek in the 17th century, while the term “biofilm” was introduced into medical microbiology by Costerton in 1982 [3]. He reported biofilm formation of S. aureus on an infected endocardial pacemaker. Microorganisms 2020, 8, 1835; doi:10.3390/microorganisms8111835 www.mdpi.com/journal/microorganisms Microorganisms 2020, 8, 1835 2 of 31 Biofilms play a prominent role in human infections. More than 80% of microbial diseases have been linked to biofilm formation. Bacterial biofilms are involved in infections of the urinary tract, the female genital tract, the bloodstream, and the upper respiratory tract [4–6]. Dental plaque, which contains streptococci and may eventually result in caries, is a prime example of a natural biofilm composed of a multispecies bacterial community. In biofilms, increased resistance to or tolerance of antibiotics is a common problem. It may be intrinsicMicroorganisms due to the 2020 microbial, 8, x FOR PEER growth REVIEW conditions or it may be caused by mutations or the exchange3 of 34 of antibiotic resistance genes [7,8]. As biofilms adapt to survive antibiotic treatment, infections are hard to eradicate2.2. Nucleic despite Acids proper antibiotic therapy [6,9,10]. Most streptococcalExtracellular DNA species (eDNA) reside is a asnother commensals major component on mucous of the membranes, biofilm matrix while. It is highly several similar pathogenic streptococcito the genomic are responsible DNA of the for bacterial life-threatening species present human within infections. the biofilm Theand is production released through of biofilms is a commonbacterial phenotypecell lysis [26] of. It commensal plays a role asin welladhesion as pathogenicand is essential species. in biofilm Commensal stabilization streptococci and biofilmsmaintenance. represent theirFurthermore, natural eDNA lifeform, provides and inprotection pathogenic against streptococcal antimicrobial species, peptides biofilms and divalent have been cations through chelation of these substances [26]. Upon the addition of nucleases to streptococcal identified as important determinants of infectious diseases. This review will focus on specifics of biofilms, significant inhibitory and disintegrating effects on biofilm formation have been observed streptococcalfor S. pneumonia, biofilms, S. theirpyogene regulation,s, as well as for and viridans the potential streptococci to interfere[27–29]. with biofilm production as a therapeutic approach. 2.3. Extracellular Proteins 2. Biofilm Composition The third major component in biofilm matrix, are extracellular proteins. Extracellular proteins Thefacilitate development reorganization, of these degradation, highly ordered andmulticellular dispersal of the communities biofilm matrix is a and complex play a multistep structural process role [11] (Figurein1 ).biofilm Durings [30] biofilm. A common formation, theme thefor several bacterial biofilm cells associated transform proteins from planktonic of Gram-positive life to bacteria an immotile life formis their [1,12 ability], resulting to form in amyloids. a complex These community include BAP consisting of S. aureus of, diEPSfferent of Enterococci, microbial and subpopulations. P1 of S. mutans [31–33]. Amyloid proteins, which assemble into insoluble fibrils, participate supportively in Biofilm formation is initiated with the adhesion of planktonic bacteria to biotic or abiotic surfaces, the cell aggregation and in biofilm formation [34]. Another form of fibrillar proteins are streptococcal developmentpili, which of microcolonies,are highly structured and cell a successive surface appendages production consisting of an extracellularof several differe matrixnt structural composed of polymericproteins. substances Their special such asrole proteins, in the formation polysaccharides, of biofilms and will extracellular be discussed DNA in a later [13]. section Three-dimensional of this structuresreview. develop The biofilm through matrix maturation however, andalso contains finally result nonfibrillar in the proteins detachment like, e.g., of singlethe Glucan bacterial-binding cells [14]. Microbialproteins cells (Gbps) in biofilm in S. mutans experience, which impaired play a signifi diffcantusion role of for nutrients biofilm formation and waste as productsthey promote with less nutrientaggregation availability and in plaque the core cohesion of the [35,36] biofilm. Furthermore [15]. In addition,, some of the due proteins to increased within the endogenous biofilm matrix oxidative stress withinare enzymes biofilms, involved microbial in the degradation cells are subjected of EPS and to spontaneousthe initiation of mutations a new biofilm [16]. lifecycleGenetic. The variations degradation of biopolymers also delivers energy and carbon sources to bacterial biofilm cells, then give rise to microbial subpopulations that are physiologically heterogeneous [17,18]. especially under limited nutrient availability [37]. FigureFigure 1. Schematic 1. Schematic diagram diagram representing representing the lifethe cyclelife cycle of biofilm of biofilm formation formation in Streptococci. in Streptococci. The The diagram showsdia thegram transition shows of the planktonic transition cellsof planktonic to sessile cells cells to by sessile undergoing cells by diundergoingfferent stages different of biofilm stages formation of and repeatingbiofilm formation the cycle and by therepeating conversion the cycle of by sessile the conversion cells to the of planktonicsessile cells stateto the again. planktonic state again. Microorganisms 2020, 8, 1835 3 of 31 The biofilm matrix is essential for protection of bacteria from environmental stresses and consists of extracellular polymeric substances (EPS). It represents an efficient diffusion barrier, interfering with the penetration of harmful substances inside the biofilm [1]. Differential gene expression is responsible for the production of EPS, which provides cohesion of the bacterial cells and determines the structure of the biofilm. Three major components are found in the biofilm matrix in varying amounts: extracellular polysaccharides, extracellular nucleic acids, and proteins can be detected together with a high percentage of water. 2.1. Extracellular Polysaccharide Microscopic evaluation of biofilms shows exopolysaccharides as elongated or branched filaments mediating the adhesion
Recommended publications
  • Prokaryotic Community Successions and Interactions in Marine Biofilms
    Prokaryotic community successions and interactions in marine biofilms: the key role of Flavobacteriia Thomas Pollet, Lyria Berdjeb, Cédric Garnier, Gaël Durrieu, Christophe Le Poupon, Benjamin Misson, Jean-François Briand To cite this version: Thomas Pollet, Lyria Berdjeb, Cédric Garnier, Gaël Durrieu, Christophe Le Poupon, et al.. Prokary- otic community successions and interactions in marine biofilms: the key role of Flavobacteriia. FEMS Microbiology Ecology, Wiley-Blackwell, 2018, 94 (6), 10.1093/femsec/fiy083. hal-02024255 HAL Id: hal-02024255 https://hal-amu.archives-ouvertes.fr/hal-02024255 Submitted on 2 Mar 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License Prokaryotic community successions and interactions in marine biofilms: the key role of Flavobacteriia Thomas Pollet, Lyria Berdjeb, Cédric Garnier, Gaël Durrieu, Christophe Le Poupon, Benjamin Misson, Jean-François Briand To cite this version: Thomas Pollet, Lyria Berdjeb, Cédric Garnier, Gaël Durrieu, Christophe
    [Show full text]
  • How to Build a Biofilm
    RESEARCH HIGHLIGHTS MICROBIOME IN brIEF Let the gut do the guiding SYMBIOSIS Growing evidence suggests that the the Gram-negative bacterium Finding the difference microbiome of animals not only Providencia, particularly Providencia The microbial gut communities of social bees comprise only affects host health but also their alcalifaciens strain JUb39, a few bacterial groups and are an emerging model system to study host-associated microbial communities. In this study, behaviour. However, the mechan- decreased avoidance of the volatile Engel and colleagues used comparative metagenomics to isms involved in the gut–brain repellent odorant octanol, an analyse the gut microbiota of two closely related honey bee axis are not well understood. effect that they refer to as octanol species, Apis mellifera and Apis cerana. Although they are In a recent study, O’Donnell, modulation. Moreover, JUb39 is colonized mostly by the same 16S rRNA phylotypes, the authors Sengupta and colleagues report that ingested by C. elegans, colonizes found that at genomic resolution, each host species harbours a gut-coloniz ing commensal bacteria the posterior intestine of the highly distinct bacterial community. Compared with A. cerana, A. mellifera displayed a much higher diversity of strains and produce a neuro trans mitter that worms and, interestingly, the extent functional gene content in the microbiota, encoding more modulates the sensory behaviour of colonization diverse enzymes for polysaccharide degradation, which may of their host. correlated with provide more metabolic flexibility. Studies are now needed The authors used chemotaxis the level to understand the mechanisms and functional consequences assays to test the influence of various of strain-level diversity among related host-associated non-pathogenic communities.
    [Show full text]
  • Fecal Bacteriology of Colonic Polyp Patients and Control Patients'
    [CANCER RESEARCH35,3407-3417,November1975] Fecal Bacteriology of Colonic Polyp Patients and Control Patients' Sydney M . Finegold,2 Dennis J . Flora, Howard R . Attebery, and Vera L. Sutter Medical Service, Wadsworth Hospital Center, Veterans Administration and Department ofMedicine, University ofCalifornia at Los Angeles School of Medicine, Los Angeles, California 9tXl24 Summary and villous adenomata are rare in populations with a low incidence of colon cancer and that they are found with the Feces from 25 subjects with colonic polyps (multiple highest incidence in areas where colon cancer has the adenomatous, large single, or single with atypia) and from highest prevalence. Berge et a!. (3) note a close association 25 matched control subjects were studied by detailed between polyps and carcinoma, both tending to occur in the quantitative aerobic and anaerobic techniques, using a large same distribution. Fifty-nine % of polypoid tumors more battery of culture media and several atmospheric condi than 10 mm in diameter were carcinomas, as were 16.9% of tions. Over 55% of organisms detected on microscopic count those 5 to 10 mm in size. were recovered anaerobically. In several cases, there were There has been much speculation on interrelationships significantly different numbers of organisms of specific between diet, intestinal bacteria, intestinal polyps, and types recovered from the two different populations studied. carcinoma (I, 2, 6—8). However, these differed from organisms with “statistical The present study was designed to compare the fecal significance― noted in a previous study from this laboratory bacterial flora of 25 patients with colonic polyps (chiefly involving two different diet groups (Japanese Americans on multiple adenomatous polyps) with that of 25 subjects either a Japanese or a Western diet).
    [Show full text]
  • The Oral Microbiome of Healthy Japanese People at the Age of 90
    applied sciences Article The Oral Microbiome of Healthy Japanese People at the Age of 90 Yoshiaki Nomura 1,* , Erika Kakuta 2, Noboru Kaneko 3, Kaname Nohno 3, Akihiro Yoshihara 4 and Nobuhiro Hanada 1 1 Department of Translational Research, Tsurumi University School of Dental Medicine, Kanagawa 230-8501, Japan; [email protected] 2 Department of Oral bacteriology, Tsurumi University School of Dental Medicine, Kanagawa 230-8501, Japan; [email protected] 3 Division of Preventive Dentistry, Faculty of Dentistry and Graduate School of Medical and Dental Science, Niigata University, Niigata 951-8514, Japan; [email protected] (N.K.); [email protected] (K.N.) 4 Division of Oral Science for Health Promotion, Faculty of Dentistry and Graduate School of Medical and Dental Science, Niigata University, Niigata 951-8514, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-45-580-8462 Received: 19 August 2020; Accepted: 15 September 2020; Published: 16 September 2020 Abstract: For a healthy oral cavity, maintaining a healthy microbiome is essential. However, data on healthy microbiomes are not sufficient. To determine the nature of the core microbiome, the oral-microbiome structure was analyzed using pyrosequencing data. Saliva samples were obtained from healthy 90-year-old participants who attended the 20-year follow-up Niigata cohort study. A total of 85 people participated in the health checkups. The study population consisted of 40 male and 45 female participants. Stimulated saliva samples were obtained by chewing paraffin wax for 5 min. The V3–V4 hypervariable regions of the 16S ribosomal RNA (rRNA) gene were amplified by PCR.
    [Show full text]
  • The Ecology of Staphylococcus Species in the Oral Cavity
    J. Med. Microbiol. Ð Vol. 50 2001), 940±946 # 2001 The Pathological Society of Great Britain and Ireland ISSN 0022-2615 REVIEW ARTICLE The ecology of Staphylococcus species in the oral cavity A. J. SMITH, M. S. JACKSON and J. BAGG Infection Research Group, Glasgow Dental Hospital and School, 378 Sauchiehall Street, Glasgow G2 3JZ Whilst the diversity of organisms present in the oral cavity is well accepted, there remains considerable controversy as to whether Staphylococcus spp. play a role in the ecology of the normal oral ¯ora. Surprisingly little detailed work has been performed on the quantitative and qualitative aspects of colonisation or infection either by coagulase- negative staphylococci CNS) or S. aureus. The latter is especially interesting in the light of present dif®culties in eradicating carriage of methicillin-resistant S. aureus MRSA) from the oropharynx in affected individuals. This paper reviews the current knowledge of staphylococcal colonisation and infection of the oral cavity in health and disease. S. aureus has been isolated from a wide range of infective oral conditions, such as angular cheilitis and parotitis. More recently, a clinical condition classi®ed as staphylococcal mucositis has emerged as a clinical problem in many debilitated elderly patients and those with oral Crohn's disease. Higher carriage rates of both CNS or S. aureus,or both, in patients prone to joint infections raises the interesting possibility of the oral cavity serving as a potential source for bacteraemic spread to compromised joint spaces. In conclusion, there is a surprising paucity of knowledge regarding the role of oral staphylococci in both health and disease.
    [Show full text]
  • Streptococcus Mutans: Has It Become Prime Perpetrator for Oral Manifestations?
    Journal of Microbiology & Experimentation Review Article Open Access Streptococcus mutans: has it become prime perpetrator for oral manifestations? Abstract Volume 7 Issue 4 - 2019 Human beings have indeed served as an incubator for a plethora of microorganisms and Vasudevan Ranganathan, CH Akhila the prominence of oral microbiome from the context of the individual’s health and well being cannot be denied. The environmental parameters and other affiliated physical Department of Microbiology, Aurora’s Degree and PG College, India conditions decide the fate of the microorganism and one of the niches in humans that supports innumerable amount of microorganisms is the oral cavity which houses Correspondence: Vasudevan Ranganathan, Department of beneficial and pathogenic microorganisms. However, majority of microorganism Microbiology, Aurora’s Degree and PG College (Affiliated to associated with humans are opportunistic pathogens which are otherwise referred to Osmania University), India-500020, Tel 8121119692, as facultative pathogens. This level of transformation in the microorganism depends Email upon the physical conditions of the oral cavity and personal hygiene maintained by the individual. The contemporary review tries to disclose the role of streptococcus Received: June 09, 2019 | Published: July 17, 2019 mutans in dental clinical conditions. The current review focuses on the prominence of Streptococcus mutans and its influence on the oral cavity. The article attempts to comprehend the role of the bacteria in causing clinical oral manifestations which depends upon the ability of the organism to utilize the substrate. The review also encompasses features like molecular entities and they role in the breakdown of the substrates leading to the formation of acids which could in turn lead to demineralization which as a consequence can negatively influence the enamel quality.
    [Show full text]
  • Structural Changes in the Oral Microbiome of the Adolescent
    www.nature.com/scientificreports OPEN Structural changes in the oral microbiome of the adolescent patients with moderate or severe dental fuorosis Qian Wang1,2, Xuelan Chen1,4, Huan Hu2, Xiaoyuan Wei3, Xiaofan Wang3, Zehui Peng4, Rui Ma4, Qian Zhao4, Jiangchao Zhao3*, Jianguo Liu1* & Feilong Deng1,2,3* Dental fuorosis is a very prevalent endemic disease. Although oral microbiome has been reported to correlate with diferent oral diseases, there appears to be an absence of research recognizing any relationship between the severity of dental fuorosis and the oral microbiome. To this end, we investigated the changes in oral microbial community structure and identifed bacterial species associated with moderate and severe dental fuorosis. Salivary samples of 42 individuals, assigned into Healthy (N = 9), Mild (N = 14) and Moderate/Severe (M&S, N = 19), were investigated using the V4 region of 16S rRNA gene. The oral microbial community structure based on Bray Curtis and Weighted Unifrac were signifcantly changed in the M&S group compared with both of Healthy and Mild. As the predominant phyla, Firmicutes and Bacteroidetes showed variation in the relative abundance among groups. The Firmicutes/Bacteroidetes (F/B) ratio was signifcantly higher in the M&S group. LEfSe analysis was used to identify diferentially represented taxa at the species level. Several genera such as Streptococcus mitis, Gemella parahaemolysans, Lactococcus lactis, and Fusobacterium nucleatum, were signifcantly more abundant in patients with moderate/severe dental fuorosis, while Prevotella melaninogenica and Schaalia odontolytica were enriched in the Healthy group. In conclusion, our study indicates oral microbiome shift in patients with moderate/severe dental fuorosis.
    [Show full text]
  • The Vicrk Two-Component System Regulates Streptococcus Mutans Virulence
    Curr. Issues Mol. Biol. (2019) 32: 167-200. DOI: https://dx.doi.org/10.21775/cimb.032.167 The VicRK Two-Component System Regulates Streptococcus mutans Virulence Lei Lei1,3#, Li Long2#, Xin Yang2, Yang Qiu2, Yanglin Zeng2, Tao Hu1, Shida Wang2*, Yuqing Li2* 1 State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Preventive Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, China 2 State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China 3 Department of Microbiology, The Forsyth Institute, Cambridge, Massachusetts, USA # Co-first author * Corresponding authors: [email protected], [email protected] Abstract: Streptococcus mutans is considered the predominant etiological agent of dental caries with the ability to form biofilm on the tooth surface. And, its abilities to obtain nutrients and metabolize fermentable dietary carbohydrates to produce acids contribute to its pathogenicity. The responses of S. mutans to environmental stresses are essential for its survival and role in cariogenesis. The VicRK system is one of the 13 putative TCS of S. mutans. The conserved caister.com/cimb 167 Curr. Issues Mol. Biol. (2019) Vol. 32 VicRK Two-Component System Lei et al functions of the VicRK signal transduction system is the key regulator of bacterial oxidative stress responses, acidification, cell wall metabolism, and biofilm formation. In this paper, it was discussed how the VicRK system regulates S. mutans virulence including bacterial physiological function, operon structure, signal transduction, and even post-transcriptional control in its regulon. Thus, this emerging subspecialty of the VicRK regulatory networks in S.
    [Show full text]
  • The Comparison of Metronidazole, Clindamycin, and Amoxicillin Againts Streptococcus Sanguinis
    Indonesian Dental Association Journal of Indonesian Dental Association http://jurnal.pdgi.or.id/index.php/jida ISSN: 2621-6183 (Print); ISSN: 2621-6175 (Online) The Comparison of Metronidazole, Clindamycin, and Amoxicillin Againts Streptococcus sanguinis Kevin Lim1, Armelia Sari Widyarman2§ 1 Undergraduate student, Faculty of Dentistry, Trisakti University, Indonesia 2 Department of Microbiology, Faculty of Dentistry, Trisakti University, Indonesia Received date: August 15, 2018. Accepted date: September 27, 2018. Published date: October 19, 2018 KEYWORDS ABSTRACT amoxicillin; Introduction: Viridans streptococci group such as Streptococcus sanguinis (S. sanguinis), an clindamycin; anaerobic Gram-positive bacteria is a well-known for its involvement in dry socket (alveolar metronidazole; Streptococcus sanguinis osteitis)-associated infection. Systemic amoxicillin, clindamycin and metronidazole have all been shown to be effective to inhibit this bacterium. However, there has been a lack of studies identifying which are the most effective amongst these antibiotics toward Streptococcus sanguinis. Objectives: The purpose of this study is to evaluate the effectiveness of metronidazole, clindamycin, and amoxicillin in inhibiting the growth of Streptococcus sanguinis in vitro. Methods: This effectiveness was done by using agar well diffusion methods. S. sanguinis ATCC 10556 were cultured in Brain Heart Infusion (BHI) broth at 37°C under anaerobic condition. After 48h, bacterial cells were harvested and counted using microplate reader (490 nm) to achieve optical density of 0.25-0.30 (107 CFU/mL). Subsequently, 100 μL of bacterial suspension was cultured on BHI agar and each antibiotic suspension was added into each agar well, incubated for 72h at 37°C. The inhibition zone diameters were measured with electronic caliper.
    [Show full text]
  • Biofire Blood Culture Identification System (BCID) Fact Sheet
    BioFire Blood Culture Identification System (BCID) Fact Sheet What is BioFire BioFire BCID is a multiplex polymerase chain reaction (PCR) test designed to BCID? identify 24 different microorganism targets and three antibiotic resistance genes from positive blood culture bottles. What is the purpose The purpose of BCID is to rapidly identify common microorganisms and of BCID? antibiotic resistance genes from positive blood cultures so that antimicrobial therapy can be quickly optimized by the physician and the antibiotic stewardship pharmacist. It is anticipated that this will result in improved patient outcomes, decreased length of stay, improved antibiotic stewardship, and decreased costs. When will BCID be BCID is performed on all initially positive blood cultures after the gram stain is routinely performed and reported. performed? When will BCID not For blood cultures on the same patient that subsequently become positive with be routinely a microorganism showing the same morphology as the initial positive blood performed? culture, BCID will not be performed. BCID will not be performed on positive blood cultures with gram positive bacilli unless Listeria is suspected. BCID will not be performed on blood culture bottles > 8 hours after becoming positive. BCID will not be performed between 10PM-7AM on weekdays and 2PM-7AM on weekends. BCID will not be performed for clinics that have specifically opted out of testing. How soon will BCID After the blood culture becomes positive and the gram stain is performed and results be available? reported, the bottle will be sent to the core Microbiology lab by routine courier. BCID testing will then be performed. It is anticipated that total turnaround time will generally be 2-3 hours after the gram stain is reported.
    [Show full text]
  • Goals of This Review Testable Concepts Fundamentals: Host
    41a –Infections in the Neutropenic Cancer Patient and Hematopoietic Stem Cell Recipients Speaker: Kieren Marr, MD Disclosures of Financial Relationships with Relevant Commercial Interests • Consultant – Amplyx, Cidara, Merck and Company, Infections in the Neutropenic Cancer Patient and Sfunga Therapeutics Hematopoietic Stem Cell Recipients • Ownership Interests – MycoMed Technologies Kieren Marr, MD Professor of Medicine and Oncology John Hopkins University School of Medicine Director, Transplant and Oncology Infectious Diseases John Hopkins University School of Medicine Goals of This Review Testable Concepts • Immune compromised people develop “typical” • Think about the patient infections and those specific to their underlying risks – How does underlying disease impact risks? • Focus here on testable complications specific to the • Think about the treatment received host – What type of immune suppression? – Types of immune – suppressing drugs and diseases • Think about infections breaking through preventative – Recognition of specific “neutropenic syndromes” therapies • Skin lesions – A good context to test resistance and differentials • Invasive fungal infections • Think about common non‐infectious syndromes • Neutropenic colitis Fundamentals: Host Immune Risks Classic Immunologic risks • Immune defects associated with underlying • Neutropenia malignancy (and prior therapies) – Prolonged (>10 days) and profound (< 500 cells / mm3) – AML and myelodysplastic syndromes (MDS) associated with high risks for severe bacterial and fungal •
    [Show full text]
  • Pdfs/ Ommended That Initial Cultures Focus on Common Pathogens, Pscmanual/9Pscssicurrent.Pdf)
    Clinical Infectious Diseases IDSA GUIDELINE A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya J. Michael Miller,1 Matthew J. Binnicker,2 Sheldon Campbell,3 Karen C. Carroll,4 Kimberle C. Chapin,5 Peter H. Gilligan,6 Mark D. Gonzalez,7 Robert C. Jerris,7 Sue C. Kehl,8 Robin Patel,2 Bobbi S. Pritt,2 Sandra S. Richter,9 Barbara Robinson-Dunn,10 Joseph D. Schwartzman,11 James W. Snyder,12 Sam Telford III,13 Elitza S. Theel,2 Richard B. Thomson Jr,14 Melvin P. Weinstein,15 and Joseph D. Yao2 1Microbiology Technical Services, LLC, Dunwoody, Georgia; 2Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; 3Yale University School of Medicine, New Haven, Connecticut; 4Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland; 5Department of Pathology, Rhode Island Hospital, Providence; 6Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill; 7Department of Pathology, Children’s Healthcare of Atlanta, Georgia; 8Medical College of Wisconsin, Milwaukee; 9Department of Laboratory Medicine, Cleveland Clinic, Ohio; 10Department of Pathology and Laboratory Medicine, Beaumont Health, Royal Oak, Michigan; 11Dartmouth- Hitchcock Medical Center, Lebanon, New Hampshire; 12Department of Pathology and Laboratory Medicine, University of Louisville, Kentucky; 13Department of Infectious Disease and Global Health, Tufts University, North Grafton, Massachusetts; 14Department of Pathology and Laboratory Medicine, NorthShore University HealthSystem, Evanston, Illinois; and 15Departments of Medicine and Pathology & Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey Contents Introduction and Executive Summary I.
    [Show full text]